Artemis Health

artemishealth.com →

-61%

est. 2Y upside i

Healthcare

Rank

#1516

Sector

Healthcare Analytics Software

Est. Liquidity

~3Y

Data Quality

Data: Medium

Artemis Health, now a key analytics unit within Nomi Health, offers a moderate upside opportunity for equity tied to its $200M internal valuation.

Last updated: March 10, 2026

Bull (30%)+200%

Artemis Health's analytics platform, as a core component of Nomi Health, significantly expands its customer base and integrates deeply into Nomi's direct care model, driving substantial cost savings and improved outcomes for employers. This success, coupled with Nomi Health achieving a higher overall valuation (e.g., through a successful IPO or larger acquisition), could see the Artemis unit's internal valuation grow to $600M, representing a 200% upside.

Base (40%)+50%

Artemis Health maintains its strong position in the healthcare analytics market within Nomi Health, continuing to grow its revenue and client base at a steady pace. Nomi Health experiences moderate growth and further solidifies its market presence. The Artemis unit's internal valuation increases to $300M, offering a 50% upside as it continues to be a valuable asset for Nomi Health.

Bear (30%)-50%

Increased competition from incumbents like IQVIA and Definitive Healthcare, or larger HR platforms, erodes Artemis Health's market share and pricing power. Integration challenges within Nomi Health or slower-than-expected adoption of Nomi's direct care model could also hinder performance. This scenario could lead to a devaluation of the Artemis unit to $100M, resulting in a 50% downside for equity holders.

Est. time to liquidity~2.5 years

Preference Stack Risk

high

Funding Intensity

29%

Artemis Health had $58M in total funding prior to its $200M acquisition by Nomi Health, representing a 29.0% investor take ratio.

Dilution Risk

moderate

As part of Nomi Health, future funding rounds for the parent company could lead to dilution of equity, although the specific impact on an Artemis-unit-tied equity grant would depend on its structure.

Secondary Liquidity

limited

Nomi Health is a private company, and while some platforms may offer limited secondary market opportunities, active secondary liquidity is not readily available.

View all 2 open roles at Artemis Health →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Artemis Health's data — designed to show you've done your homework.

  • 1

    “Given Artemis Health's acquisition by Nomi Health, how is the team thinking about balancing the continued growth and innovation of the Artemis platform with Nomi Health's broader direct care and payment solutions?”

  • 2

    “With Nomi Health's estimated $95.4M in annual revenue and its focus on disrupting healthcare payments, what are the key metrics and strategic initiatives for Artemis Health specifically to contribute to Nomi Health's overall growth and market penetration over the next 24 months?”

  • 3

    “Considering Nomi Health's Series A/B stage and recent funding rounds, what is the anticipated timeline for a liquidity event (e.g., IPO or further acquisition) that would provide a return on employee equity, and how are RSUs/options structured to account for the preference stack from prior funding?”

Community

Valuation Sentiment

Our model estimates -61% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.